¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"Androderm Transdermal System CIII"¿¡ ´ëÇÑ ´ëÇÑ»ýÈÇкÐÀÚ»ý¹°ÇÐȸ ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑ»ýÈÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
isolated system
°Ý¸®(̰×î)½Ã½ºÅÛ
Kovats retention index system
ÄÚ¹ÙÆ® ü·ù(ôò׺) Áö¼ö(ò¦â¦)½Ã½ºÅÛ
K system
K ½Ã½ºÅÛ
leiotonin system
¶óÀÌ¿ÀÅä´Ñ ½Ã½ºÅÛ
MN blood group system
MN½Ä(ãÒ)Ç÷¾×Çü(úìäûúþ)
model system
¸ðµ¨½Ã½ºÅÛ
multienzyme system
´ÙÈ¿¼Ò(Òýý£áÈ)½Ã½ºÅÛ
multisubstrate enzyme system
´Ù±âÁúÈ¿¼Ò(ÒýѨòõý£áÈ) ½Ã½ºÅÛ
open-circuit system
°³¹æÈ¸·Î(ËÒÛ¯üÞÖØ) ½Ã½ºÅÛ
open system
°³¹æ(ËÒÛ¯) ½Ã½ºÅÛ
optical system
±¤(ÎÃ) ½Ã½ºÅÛ
phosphotransferase system
Æ÷½ºÆ÷Æ®¶õ½ºÆÛ·¹À̽º ½Ã½ºÅÛ
protein-synthesizing system
´Ü¹éÁú ÇÕ¼º(Ó±ÛÜòõùêà÷) ½Ã½ºÅÛ
repressible system
¾ïÁ¦¼º ½Ã½ºÅÛ
restriction-modification system
Á¦ÇÑ ¼ö½Ä(áóãÞ) ½Ã½ºÅÛ
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑ»ýÈÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½